» Articles » PMID: 17983372

Health-related Quality of Life in Allergic Rhinitis: Comparing the Short Form ESPRINT-15 and MiniRQLQ Questionnaires

Overview
Journal Allergy
Date 2007 Nov 7
PMID 17983372
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We compared the psychometric properties of the ESPRINT-15, the short form of a new Spanish instrument to measure health-related quality of life in allergic rhinitis (AR) patients, with those of the Mini-Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ).

Methods: The questionnaires were compared in Spanish patients with intermittent allergic rhinitis (IAR) or persistent AR in a prospective, observational study. Floor and ceiling effects, internal consistency (Cronbach's alpha), test-retest reliability (intraclass correlation coefficient; ICC), convergent and known groups validity, and sensitivity to change (standardized response means; SRMs) were compared.

Results: In terms of content, while the MiniRQLQ has a dimension covering practical problems and places more emphasis on symptoms, the ESPRINT-15 has two dimensions (Sleep and Psychological impact) which are not included in the MiniRQLQ. In the validation study, 400 patients were included and 59% of the sample had persistent AR. There were no significant floor or ceiling effects on any dimension on either questionnaire. Cronbach's alpha values for the ESPRINT-15 and MiniRQLQ overall scores were 0.92 and 0.90, respectively. In 48 clinically stable patients, ICCs were 0.80 and 0.77, respectively. Both instruments discriminated between patients with IAR and persistent AR. Correlations with symptom scores and generic measures were moderate to strong. SRMs for overall scores and individual dimensions on the two questionnaires in the 197 patients reporting a change in health status ranged from 0.7 to 1.3.

Conclusions: Both questionnaires performed well in psychometric terms. The ESPRINT-15 is particularly recommended for use in Spanish-speaking populations.

Citing Articles

Development and validation of a health practitioner survey on ocular allergy.

Mikhail E, Mohebbi M, Gokhale M, Azizoglu S, Suphioglu C Sci Rep. 2024; 14(1):9932.

PMID: 38689009 PMC: 11061311. DOI: 10.1038/s41598-024-60837-6.


Classic test and generalizability theories are both useful for cross-cultural adaptation of an allergic rhinitis health-related quality of life questionnaire.

Yepes-Nunez J, Cardenas E, Gomez-Garcia C, Manco Sepulveda M, Martinez L, Valero A World Allergy Organ J. 2021; 14(12):100612.

PMID: 34934472 PMC: 8640560. DOI: 10.1016/j.waojou.2021.100612.


Relationship between allergic rhinitis and diamine oxidase activity: A preliminary report.

Mayo-Yanez M, Diaz-Diaz A, Vazquez-Barro J, Gonzalez-Botas J, Figueroa A, Martin-Martin C Allergol Select. 2021; 5:187-194.

PMID: 34235375 PMC: 8240126. DOI: 10.5414/ALS400537.


Physicians' prescribing behaviour and clinical practice patterns for allergic rhinitis management in Italy.

Passalacqua G, Musarra A, Senna G, Bousquet J, Ferrara C, Lonati C Clin Mol Allergy. 2020; 18(1):20.

PMID: 33292294 PMC: 7640419. DOI: 10.1186/s12948-020-00135-4.


Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis.

Valero A, Izquierdo I, Kowalski M, Scadding G, Bousquet J, Mullol J Allergy Asthma Clin Immunol. 2020; 16:29.

PMID: 32346387 PMC: 7181536. DOI: 10.1186/s13223-020-00425-1.